Group of markers for diagnosing recurrent abortion and application thereof
A technology for recurrent miscarriage and products, applied in the field of biomedicine, can solve problems such as miscarriage and affecting embryo growth and development
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1 Differential protein screening
[0037] 1. Clinical data
[0038] 1.1 Case source:
[0039] 1.2 Case grouping: 12 serum samples from women with normal pregnancy history (normal group), 24 serum samples from recurrent abortion patients caused by prethrombotic state (prethrombotic state group), serum samples from recurrent abortion patients not caused by prethrombotic state Samples of 12 cases (non-thrombotic state group).
[0040] 1.3 Number of cases:
[0041] Protein microarray detection: 12 cases in the normal group, 24 cases in the prethrombotic state group, and 12 cases in the non-prothrombotic state group.
[0042] 2. Materials and instruments used in the present invention
[0043] 2.1 Kit: QAH-CAA-440 kit, kit contains:
[0044] The kit is stored at -20°C. After starting to use, slide chips, cytokine standard mixed powder, detection antibody mixture, Cy3-streptavidin should be stored at -20°C, and other reagents should be stored at 4°C to avoid repea...
Embodiment 2
[0114] Example 2 Differential Protein Verification
[0115] The differential protein verification method is the same as in Example 1.
[0116] 1. Verification of protein differences between non-prothrombotic state group, prethrombotic state group and normal group
[0117] In the results of the preliminary screening, the inventor found that 38 proteins were significantly up-regulated or down-regulated in the disease group compared with the normal group. In order to further confirm the differential expression of these proteins, the inventor selected 20 proteins for verification. The samples tested were 58 cases in the prethrombotic state group, 34 cases in the non-thrombotic state group, and 25 cases in the normal group.
[0118] The results showed that in the verified results, 10 proteins were differentially expressed in the disease group compared with the normal group, 4 of which were up-regulated and 6 were down-regulated, as shown in Table 7.
[0119] Table 7 Verify the di...
Embodiment 3
[0130] Embodiment 3 receiver operating characteristic (ROC) curve analysis
[0131] A receiver operating characteristic curve was constructed to compare the diagnostic ability of 38 serum markers to distinguish recurrent abortion patients from healthy controls. Due to the large number, the ROC curves of six serum markers are given as reference examples, such as Figure 9 shown. Under the optimal cutoff value, the sensitivity of the 38 serum markers was between 0.741-0.920, the specificity was between 0.603-0.845 and the AUC value was between 0.750-0.901.
[0132] The combined AUC of these 38 serum markers can reach 0.966, and the sensitivity and specificity are 1.00 and 0.862 respectively (such as Figure 10 shown). These results indicated that, compared with 38 protein markers for recurrent miscarriage alone, the combination of 38 markers had higher sensitivity and specificity for early detection of recurrent miscarriage.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com